Upon recommendation of the Nominating and Governance Committee of the Board of Directors of Bionano Genomics, Inc. (the Company), on February 17, 2022, the Board appointed Aleksandar Rajkovic as a Class III director, effective as of such date, to serve in such capacity until the Company's 2024 annual meeting of stockholders. Dr. Rajkovic will receive compensation for his service as a director in accordance with the Company's Non-Employee Director Compensation Policy, as amended (the Compensation Policy).
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.965 USD | -0.74% | -10.03% | -49.06% |
05-28 | Bionano Genomics Raises $18 Million From Private Debentures Placement | MT |
05-24 | Bionano Genomics, Inc. announced that it has received $18 million in funding | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-49.06% | 67.19M | |
+5.73% | 215B | |
+9.76% | 187B | |
+17.55% | 143B | |
+29.10% | 110B | |
+1.48% | 64.68B | |
+13.57% | 52.96B | |
-0.16% | 49.84B | |
-5.07% | 38.32B | |
+0.13% | 35.86B |
- Stock Market
- Equities
- BNGO Stock
- News Bionano Genomics, Inc.
- Bionano Genomics, Inc. Appoints Aleksandar Rajkovic as Class III Director